TC BioPharm have joined forces with University College London to develop treatment for Leukaemia. The agreement aims to progress UCL’s gene-modified T cell therapies that are capable of treating cancers of the blood. To read the full article, click here.
Scotland’s First Minister, Nicola Sturgeon opened ReproCell’s European Headquarters in Glasgow. The new headquarters will allow ReproCell to generate new employment opportunities in Scotland whilst strengthening targeted drug discovery and translational research. To read the full article, click here.
Scottish bio-tech company has been awarded €4million to develop its pioneering cancer treatment. This is the largest EU award to any Scottish company for healthcare therapeutic product. The recipients of the award, TC BioPharm(TCB) announced the investment which will aide in their development of GTD cell therapy treatment for cancer. The research will allow the therapeutic cells derived from a single donor to treat several...